← SynDRA
OMAVELOXOLONE
SynDRA canonical compound SYN0039856 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | NFE2L2 |
| Mechanism of action | nitric oxide production inhibitor |
All known targets
Mechanisms of action (all sources)
- NFE2L2 ACTIVATOR
- Nuclear factor erythroid 2-related factor 2 activator
- nitric oxide production inhibitor
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- HLAB
- IFNB1
- KSYK
- NSD2
- PARP1
- SYK
Drug classes
- Cytochrome P450 3A4 Inducers
- Cytochrome P450 2C8 Inducers
ATC classes
- N07X · OTHER NERVOUS SYSTEM DRUGS
Cross-references
Synonyms
- SKYCLARYS
- Skyclarys
- skyclarys
- RTA-408
- Omaveloxolona
- RJCWBNBKOKFWNY-HGNIWHNWSA-N
- AKOS030526563
- RTA 408
- G69Z98951Q
- omaveloxolona
- omaveloxolonum
- RefChem:58294
- DTXCID301569878
- Nrf1-activator-1
- Omaveloxolone [INN]
- RTA408
- MFCD28167769
- UNII-G69Z98951Q
- Skyclarys (TN)
- Omaveloxolone (USAN/INN)
- RTA-408(Omaveloxolone)?
- OMAVELOXOLONE [USAN]
- OMAVELOXOLONE [WHO-DD]
- GTPL7573
- orb1300346
- SCHEMBL15349371
- EX-A541
- C33H44F2N2O3
- CHEBI:229661
- RJCWBNBKOKFWNY-IDPLTSGASA-N
- GLXC-90493
- AKOS037648676
- NCGC00390577-04
- AC-37100
- BS-15146
- HY-12212
- SY284909
- NS00073426
Look up OMAVELOXOLONE in the interactive SynDRA portal →